Comprehensive Diagnostic & Therapeutic Reference Profile
Also known as: Internal endometriosis, uterine adenomyosis, endometriosis interna.
Adenomyosis is a benign gynecological condition characterized by the presence of endometrial-like glands and stroma within the myometrium (the muscular layer of the uterus). This invasion causes hypertrophy and hyperplasia of the surrounding smooth muscle, often resulting in a globally enlarged, "boggy" uterus. It is frequently associated with pelvic pain, abnormal uterine bleeding, and infertility.
The exact etiology remains idiopathic, though theories suggest the breakdown of the natural barrier between the endometrium and myometrium. Factors include postpartum uterine trauma, mechanical damage from surgeries (C-sections), or the metaplasia of pluripotent stem cells within the myometrium. Hormonal imbalances, specifically high estrogen levels, are known to fuel the proliferation of ectopic endometrial tissue.
The primary mechanism involves the invagination of the stratum basalis of the endometrium into the myometrium. This creates "adenomyotic nests" that maintain cyclic responsiveness to hormones. Chronic inflammation ensues, causing focal or diffuse enlargement of the uterus. The loss of the normal junctional zone architecture leads to hyper-peristalsis of the uterus, causing painful uterine contractions.
Adenomyosis affects approximately 10β20% of women, though prevalence estimates vary significantly based on diagnostic criteria (imaging vs. histology). It is most commonly diagnosed in multiparous women between the ages of 35 and
50.
A. Early Symptoms
Bimanual examination typically reveals a symmetrically enlarged, firm, yet tender uterus. It may feel "boggy" or mobile, depending on the severity of the adenomyotic foci.
A. Clinical Assessment: History of dysmenorrhea and menorrhagia.
B. Laboratory Testing: CBC to assess for anemia.
C. Imaging Studies: Transvaginal ultrasound (TVUS) and MRI.
D. Functional Tests: Not applicable.
E. Biopsy Findings: Histopathology (post-hysterectomy gold standard).
F. Genetic Testing: Not indicated.
G. Differential Diagnosis: Uterine fibroids, endometriosis, endometrial cancer.
Complete Blood Count (CBC)
Type: Blood Test
Purpose: Evaluate anemia resulting from menorrhagia.
Expected Findings: Low hemoglobin/hematocrit.
Interpretation: Indicates chronic blood loss requiring iron supplementation.
Severe anemia, infertility, chronic pain syndromes, psychological distress.
A. Lifestyle Modifications: NSAIDs for pain, heat therapy.
B. Preventive Measures: Early management of menstrual symptoms.
C. Medical Treatment
Good for symptom relief; however, complete resolution typically requires hysterectomy. Fertility may be impaired but can be managed with fertility specialists.
No definitive prevention; early diagnosis helps manage disease progression.
The following homeopathic remedies have been historically indicated for symptoms associated with Adenomyosis. Selection should be based on individualized symptom totality and constitutional assessment.
This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.
Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Adenomyosis.
Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, identify reference range variances, and generate a plain-English explanation of your disease risks.
Browse our full library of 200+ medical and pathology calculators.
π Browse All CalculatorsSpeak with our specialists for a customized treatment protocol for this condition.
π Request ConsultationThis clinical reference is for educational purposes only. It is not a substitute for professional medical diagnosis or treatment. Always consult a licensed healthcare practitioner.